Harrow (HROW) Intangibles (2014 - 2026)
Harrow (HROW) posted Intangibles of $175.6 million for Q2 2026, down 22.44% on a QoQ basis from $226.4 million in Q1 2026, and down 15.88% year-over-year from $208.7 million in Q2 2025.
Analysis
Harrow (HROW) Intangibles (2014 - 2026) Analysis & Trends
Harrow has reported Intangibles for 13 years, with the latest figure at $175.6 million in Q2 2026.
- On a quarterly basis, Intangibles fell 15.88% year-over-year to $175.6 million in Q2 2026; TTM through Jun 2026 was $175.6 million, a 15.88% decrease from a year earlier, with the FY2025 full-year figure at $175.2 million, down 16.19% from the prior year.
- Intangibles was $175.6 million for Q2 2026 at Harrow, down from $226.4 million in the prior quarter.
- The five-year high for Intangibles was $226.4 million in Q1 2026, with the low at $16.5 million in Q2 2022.
- Average Intangibles over 5 years is $150.3 million, with a median of $172.4 million recorded in 2023.
- The sharpest annual moves came in 2023 and 2025: Intangibles surged 850.38% in 2023, then decreased 16.19% in 2025.
- Over 5 years, Intangibles stood at $26.7 million in 2022, then surged by 545.41% to $172.4 million in 2023, then grew by 21.21% to $209.0 million in 2024, then declined by 16.19% to $175.2 million in 2025, then climbed by 0.23% to $175.6 million in 2026.
- The last three Intangibles figures came in at $175.6 million (Q2 2026), $226.4 million (Q1 2026), and $175.2 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.47 Bn | 624.71 Bn | 17.26 Bn | 48.23 Bn |
| 2 | AbbVie | 439.99 Bn | 433.42 Bn | 12.70 Bn | 49.14 Bn |
| 3 | Merck | 365.45 Bn | 358.31 Bn | 12.21 Bn | 24.98 Bn |
| 4 | Novartis Ag | 266.57 Bn | 258.88 Bn | 11.24 Bn | 42.07 Bn |
| 5 | Pfizer | 159.03 Bn | 147.33 Bn | 10.94 Bn | 47.05 Bn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | 30.64 Bn |
| 7 | Revolution Medicines | 44.23 Bn | 44.23 Bn | - | 63.28 Mn |
| 8 | Incyte | 25.32 Bn | 20.79 Bn | 1.57 Bn | 103.20 Mn |
| 9 | United Therapeutics | 21.44 Bn | 18.77 Bn | 683.80 Mn | - |
| 10 | Harrow | 1.42 Bn | 1.33 Bn | 50.36 Mn | 175.57 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 175.57 Mn |
| Mar 31, 2026 | 226.37 Mn |
| Dec 31, 2025 | 175.17 Mn |
| Sep 30, 2025 | 208.74 Mn |
| Jun 30, 2025 | 208.72 Mn |
| Mar 31, 2025 | 208.59 Mn |
| Dec 31, 2024 | 209.02 Mn |
| Sep 30, 2024 | 209.01 Mn |
| Jun 30, 2024 | 172.02 Mn |
| Mar 31, 2024 | 171.96 Mn |
| Dec 31, 2023 | 172.45 Mn |
| Sep 30, 2023 | 172.43 Mn |
| Jun 30, 2023 | 157.27 Mn |
| Mar 31, 2023 | 156.27 Mn |
| Dec 31, 2022 | 26.72 Mn |
| Sep 30, 2022 | 21.56 Mn |
| Jun 30, 2022 | 16.55 Mn |
| Mar 31, 2022 | 16.55 Mn |
| Dec 31, 2021 | 16.64 Mn |
| Sep 30, 2021 | 2.58 Mn |